Drug-induced autoimmune hemolytic anemia

MONDO:0019535

Drug-induced autoimmune hemolytic anemia is a type of autoimmune hemolytic anemia (AIHA) that occurs as a reaction to therapeutic drugs, and can be due to various mechanisms.

Also known as: drug-induced AIHA

44 clinical trials for this condition and its sub-types, 0 tagged with Drug-induced autoimmune hemolytic anemia itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Autoimmune hemolytic anemia (72)

Including sub-types (44) Tagged with Drug-induced autoimmune hemolytic anemia (0)

Trials to join now! 16 Not yet recruiting 11 Not yet finished but already full! 6 Completed 10 Terminated 1

Biopsy tolerance study ends early – what we know

Knowledge-focused Stopped early

This study aimed to understand how well patients tolerate biopsies for autoimmune diseases and whether they feel properly informed. It planned to enroll 505 people but was terminated early. The results may help improve patient experience with these common procedures.

Sponsor: University Hospital, Brest • Aim: Knowledge-focused

Last updated Jun 28, 2026 00:00 UTC

Drug-induced autoimmune hemolytic anemia

Where it sits in the disease tree

Biopsy tolerance study ends early – what we know